Story
ELF Beauty Stock Rises on Accelerating Sales Data and Analyst Upgrade
Summary
Shares of e.l.f. Beauty gained 3.7% after new data showed accelerating sales growth and B. Riley raised its price target, citing momentum from the company's European expansion.
Shares of e.l.f. Beauty, Inc. (NYSE: ELF) rallied on Tuesday, buoyed by a combination of accelerating sales data, a bullish analyst price target revision, and momentum from a key European brand launch.
The stock closed up 3.7% at $104.75, outperforming the broader market indices which posted only modest gains.
Accelerating Sales Data
The primary catalyst for the stock's move was proprietary data from Canaccord's beauty sales tracker. According to the firm's report, e.l.f. Beauty saw significant growth in the two weeks ending September 20:
- Dollar sales growth of 11.6% year-over-year.
- Unit growth of 17.0% year-over-year.
This represents a notable acceleration from the 9.0% growth recorded in the prior two-week period, according to the source. The data also highlighted the strength of its Naturium skincare brand, which posted a 74.3% sales surge in the same window.
Analyst Confidence and European Expansion
AdWall Street sentiment provided an additional tailwind for the shares. Analysts at B. Riley recently raised their price target on ELF to $115 from a previous level, reiterating a Buy rating on the stock. The firm pointed to strong demand for the rhode brand ahead of its European retail debut.
That launch, which went live on September 30, expands rhode's presence into 19 European countries through Sephora's retail and online channels. This move is widely viewed by analysts as a significant step in the company's international growth strategy. Separately, analysts at Bernstein maintain an Outperform rating with a $127 price target, citing the company's effective use of social media and rapid product innovation.
Market Context
Tuesday's rally pushed ELF shares higher after a prior close of $100.97, though the stock remains below its 52-week high of $147.75. The strong sales data has investors looking ahead to the company's next quarterly earnings report, which is confirmed for November 4, 2026.
The combination of improving real-time sales metrics, positive analyst commentary, and the strategic European launch provided a strong foundation for the stock's outperformance.
Read next
More on Stocks
Raymond James Swaps Healthcare Top Picks for October, Adds UnitedHealth, Xencor, and Calyxt
Investment firm Raymond James has revised its Healthcare Top Picks list for October, adding UnitedHealth, Xencor, and Calyxt while removing three others. The firm cited upcoming catalysts and attractive valuations as key drivers for the changes.
Boeing Shares Rise as Engineers Ratify Contract, Averting Strike Risk
Boeing stock climbed about 4% after its largest white-collar union, SPEEA, approved a new four-year labor agreement. The deal prevents a work stoppage that could have disrupted key aircraft certification and production goals.
Pritzker Private Capital Explores Sale of Propane Distributor EDP for Over $1 Billion
The private equity firm is reportedly working with advisors on a potential sale of Energy Distribution Partners, a deal that could value the propane and light fuels company at more than $1 billion including debt.
Anthropic Reportedly Schedules Pre-IPO Investor Day for October 14
The AI research firm, a major competitor to OpenAI, is said to be holding a key meeting with institutional investors on Oct. 14, a significant move toward a potential stock market debut, according to a Bloomberg report.